Author

O. Guirola

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Y. Ramos· 3 shared J. R. Wisniewski· 2 shared L. J. Gonzalez· 2 shared V. Besada· 2 shared A. C. Ramon· 1 shared A. Hardy-Sosa· 1 shared A. M. Martin· 1 shared A. Marcello· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Y. Ramos

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Proteomics and phosphoproteomics profiling of the co-formulation of type I and II interferons, HeberFERON, in the glioblastoma-derived cell line U-87 MG

D. Vazquez-Blomquist, A. Hardy-Sosa, S. C. Baez, V. Besada, S. Palomares, O. Guirola, Y. Ramos, J. R. Wisniewski, L. J. Gonzalez, I. Bello-Rivero

This study uses proteomic and phosphoproteomic analyses to investigate the effects of HeberFERON on U-87 MG glioblastoma cells, identifying key pathways and phosphosites involved in antiproliferative responses.

bioRxiv · Oct 3, 2022 · PreprintCancer Biology

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

M. Rosales, A. Rodriguez-Ulloa, V. Besada, A. C. Ramon, G. V. Perez, Y. Ramos, O. Guirola, L. J. Gonzalez, K. Zettl, J. R. Wisniewski, Y. Perera, S. E. Perea

This study examines the phosphoproteomic changes in AML cell lines treated with CX-4945, identifying key biological processes and pathways affected by CK2 inhibition.

bioRxiv · Jan 4, 2021Cancer Biology

The low-density lipoprotein receptor-related protein-1 is essential for Dengue virus infection

V. Huerta Galindo, A. M. Martin, M. Sarria, O. Guirola, A. Yero, Y. Ramos, D. Pupo, D. Martin, A. Marcello, G. Chinea

This paper identifies LRP1 as a new receptor for Dengue virus entry, showing it binds the viral envelope protein and inhibits infection, suggesting it as a potential drug target.

bioRxiv · Jun 10, 2020Biochemistry